Takeaways from IDWeek 2016
Tru-D continues to be validated by leading researchers and was included in several presentations at IDWeek
in New Orleans, Louisiana, October 26-30, 2016. Dr. William A. Rutala and other researchers from the Benefits of Enhanced Terminal Room Disinfection (BETR-D) study released a poster abstract demonstrating Tru-D’s effectiveness in reducing 94% of MDROs and a 35% decrease in infection rates. See poster below. This smaller study was completed contemporaneously with the BETR-D study; the full results of the BETR-D study will be published soon in The Lancet.
Individual hospital results may vary based on numerous factors including adherence to standard disinfection protocol.
Further, UPMC reported results on using Tru-D to control an outbreak of Acinetobacter. According to their findings, “Focused attention to hand hygiene, personal protective equipment and enhanced environmental disinfection to include UV disinfection were important interventions in stemming this outbreak of Acinetobacter.” See poster below.
Lastly, Dr. Deverick Anderson presented on enhanced terminal room disinfection technologies and stressed the importance of adopting such technologies in health care environments. According to Anderson, when asked why the researchers chose Tru-D for the BETR-D study, he stated, “When it comes to the use of the machine, we used Tru-D which has sensors. Those machines run until they have the sufficient amount of reflected UV.” Tru-D’s Sensor360 technology
measures the amount of UV energy reflected back while eliminating the chance of human error in the disinfection process.
To read more, click here
or to have a member of our sales team contact you, please e-mail firstname.lastname@example.org